Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma

Tania Jain; Craig S. Sauter; Gunjan L. Shah; Molly A. Maloy; Jason Chan; Michael Scordo; Scott T. Avecilla; Yakup Batlevi; Parastoo B. Dahi; Connie W. Batlevi; M. Lia Palomba; Sergio A. Giralt; Miguel Angel Perales

doi:10.1038/s41375-019-0476-y

Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma

Tania Jain, Craig S. Sauter, Gunjan L. Shah, Molly A. Maloy, Jason Chan, Michael Scordo, Scott T. Avecilla, Yakup Batlevi, Parastoo B. Dahi, Connie W. Batlevi, M. Lia Palomba, Sergio A. Giralt, Miguel Angel Perales

Research output: Contribution to journal › Letter › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	2540-2544
Number of pages	5
Journal	Leukemia
Volume	33
Issue number	10
DOIs	https://doi.org/10.1038/s41375-019-0476-y
State	Published - Oct 1 2019
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-019-0476-y

Cite this

Jain, T., Sauter, C. S., Shah, G. L., Maloy, M. A., Chan, J., Scordo, M., Avecilla, S. T., Batlevi, Y., Dahi, P. B., Batlevi, C. W., Lia Palomba, M., Giralt, S. A., & Perales, M. A. (2019). Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma. Leukemia, 33(10), 2540-2544. https://doi.org/10.1038/s41375-019-0476-y

Jain, T, Sauter, CS, Shah, GL, Maloy, MA, Chan, J, Scordo, M, Avecilla, ST, Batlevi, Y, Dahi, PB, Batlevi, CW, Lia Palomba, M, Giralt, SA & Perales, MA 2019, 'Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma', Leukemia, vol. 33, no. 10, pp. 2540-2544. https://doi.org/10.1038/s41375-019-0476-y

@article{6508f0d3e0b74d4788e17b125f053bb9,

title = "Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma",

author = "Tania Jain and Sauter, {Craig S.} and Shah, {Gunjan L.} and Maloy, {Molly A.} and Jason Chan and Michael Scordo and Avecilla, {Scott T.} and Yakup Batlevi and Dahi, {Parastoo B.} and Batlevi, {Connie W.} and {Lia Palomba}, M. and Giralt, {Sergio A.} and Perales, {Miguel Angel}",

year = "2019",

month = oct,

day = "1",

doi = "10.1038/s41375-019-0476-y",

language = "English (US)",

volume = "33",

pages = "2540--2544",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma

AU - Jain, Tania

AU - Sauter, Craig S.

AU - Shah, Gunjan L.

AU - Maloy, Molly A.

AU - Chan, Jason

AU - Scordo, Michael

AU - Avecilla, Scott T.

AU - Batlevi, Yakup

AU - Dahi, Parastoo B.

AU - Batlevi, Connie W.

AU - Lia Palomba, M.

AU - Giralt, Sergio A.

AU - Perales, Miguel Angel

PY - 2019/10/1

Y1 - 2019/10/1

UR - http://www.scopus.com/inward/record.url?scp=85066140851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066140851&partnerID=8YFLogxK

U2 - 10.1038/s41375-019-0476-y

DO - 10.1038/s41375-019-0476-y

M3 - Letter

C2 - 31114023

AN - SCOPUS:85066140851

SN - 0887-6924

VL - 33

SP - 2540

EP - 2544

JO - Leukemia

JF - Leukemia

IS - 10

ER -

Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this